GT Biopharma (GTBP) Asset Utilization Ratio (2011 - 2016)

GT Biopharma (GTBP) posted quarterly Asset Utilization Ratio of 0.44 for Q1 2016, down 35.36% quarter-over-quarter from 0.68 in Q1 2014.

GT Biopharma (GTBP) Asset Utilization Ratio (2011 - 2016) Analysis & Trends

GT Biopharma (GTBP) has reported Asset Utilization Ratio for 5 consecutive years, with 0.44 the latest figure, recorded in Q1 2016.

In Q1 2016, Asset Utilization Ratio changed N/A year-over-year to 0.44; the TTM figure through Mar 2016 stood at 0.44 (changed N/A YoY), while the FY2015 annual figure was 0.06, up 5.95% from the prior year.
Asset Utilization Ratio eased to 0.44 in Q1 2016 per GTBP's latest filing, from 0.68 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 1.17 in Q3 2012 and bottomed at 0.01 in Q4 2012.
Historically, Asset Utilization Ratio has averaged 0.41 across 4 years, with a median of 0.44 in 2016.
Annual changes were most pronounced in 2012 — Asset Utilization Ratio tumbled 106.12% — and 2013, when it surged 953.57%.
GT Biopharma's Asset Utilization Ratio stood at 0.01 in 2012, then soared by 7950.0% to 0.5 in 2013, then surged by 36.0% to 0.68 in 2014, then sank by 35.36% to 0.44 in 2016.
Business Quant data shows GTBP's Asset Utilization Ratio at 0.44 in Q1 2016, 0.68 in Q1 2014, and 0.5 in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.38
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.90
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.13
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	GT Biopharma	8.64 Mn	8.64 Mn	-	-

Download Data